3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Conditions
Inflammation
2
Frailty
2
Uterine Cervical Dysplasia
1
Squamous Intraepithelial Lesions
1
Prostatic Neoplasms
1
Papillomavirus Infections
1
Liver Neoplasms
1
Liver Cirrhosis
1
Leiomyoma
1
Esophageal Neoplasms
1
Deglutition Disorders
1
Carcinoma, Hepatocellular
1
Atypical Squamous Cells of the Cervix
1
Interventions
epigallocatechin gallate
2
Ascorbic Acid
2
peflavit
1
microcrystalline cellulose
1
fisetin
1
cabozantinib
1
Temozolomide
1
Quercetin
1
Protons
1
Photons
1
Flavonoids
1
Dasatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2
×
Frailty
×
epigallocatechin gallate
×
Clear all
NCT04553666
2026-05-07
ReFOCUS1
University of Rochester
Phase 2
Completed
24 enrolled
17 charts
NCT06068543
2026-03-06
ReFOCUS2
University of Rochester
Phase 2
Recruiting
118 enrolled